CYP21-catalyzed production of the long-term urinary metandienone metabolite 17i-hydroxymethyl-17i-methyl-18-norandrosta-1, 4, 13-trien-3-one a contribution toae
Revision as of 22:08, 11 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == CYP21-catalyzed production of the long-term urinary metandienone metabolite 17i-hydroxymethyl-17i-methyl-18-norandrosta-1, 4, 13-trien-3-one a contribution toae; A Zallner, MK Parr, CA Dragan, S Drasae; 2010; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Huly...")
Target Article[edit | edit source]
CYP21-catalyzed production of the long-term urinary metandienone metabolite 17i-hydroxymethyl-17i-methyl-18-norandrosta-1, 4, 13-trien-3-one a contribution toae; A Zallner, MK Parr, CA Dragan, S Drasae; 2010; doi_citing_unknown
Retraction[edit | edit source]
Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000
Citation piece[edit | edit source]
Note: Open to append information.